Kyiv, January 28th 2026 | Servier Ukraine LLC, a subsidiary of Servier, a global pharmaceutical group, has been certified for the fourth consecutive time as one of the best places to work for in Ukraine.
Best Places to Work is an international HR certification program providing employers in different countries the opportunity to learn more about the engagement and satisfaction of their employees and honor those who deliver an outstanding work experience with the highest standards in regards to working conditions.
The certification process consisted of an employee assessment survey conducted among Servier Ukraine employees along with an HR Assessment evaluating people practices implemented within the organisation. The key areas covered included leadership, compensation and benefits, recruitment and onboarding, employee engagement, corporate social responsibility, culture, and personal growth opportunities. Servier Ukraine obtained outstanding scores across all employee engagement factors.
“At Servier Ukraine, we have always believed that our success reflects our people’s spirit. Being certified as a Best Place to Work once again is not just an award; it is a testament to the trust, resilience, and passion that define our team. Together, as one Team, we are building more than a workplace; we are fostering a community united by a shared purpose: to improve the lives of patients. This recognition inspires us to continue nurturing a culture where every individual is empowered to grow and make a meaningful impact on society”, said Benjamin Abdili, General Manager, Servier Ukraine.
“Creating a workplace where collaboration flourishes and individuals feel empowered is at the heart of our HR strategy. This certification confirms that we are prioritizing the right things: the safety, development, and engagement of our colleagues. Our team’s ability to remain focused and inspired, despite external challenges, is truly remarkable. We are dedicated to maintaining Servier Ukraine’s position as an employer of choice by listening to our employees and building a future where everyone feels they truly belong”, said Olha Shylova, HR&LD Director, Servier Ukraine.
About SERVIER
Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long-term innovation, with 100% of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe. Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70% of its R&D budget to this field. By leveraging precision medicine, Servier develops therapies that are more targeted and more effective. Bolstered by its success in oncology, Servier has expanded into neurology, a key driver of future growth. The Group focuses on a select number of neurodegenerative diseases, where accurate patient profiling enables targeted therapeutic responses through precision medicine. To further enhance access to high-quality, affordable care, Servier also provides an extensive range of generic medicines, building on well-established brands in France, Eastern Europe, and Brazil. In all its activities and at every stage of the medicine life cycle, the Group integrates the patient’s voice. Headquartered in France, Servier operates in close to 140 countries. In 2023-2024, the Group, which employs over 22,000 people worldwide, achieved sales revenue of €5.9 billion.
In Ukraine Servier operates 25 years.
More information on the new Group website: servier.com |servier.ua
Follow us on social media: LinkedIn, Facebook, Twitter, Instagram
Contacts for Media requests in Ukraine:
Hanna Akopian, Communications Manager | hanna.akopin@servier.com | +380 44 490 34 41
